Introduction
Flavin-dependent monooxygenases (FMOs), alongside cytochrome P450 enzymes, are one of two prominent families of monooxygenases in eukaryotes (Cashman, 2001) . They are found throughout all phyla (Hao et al., 2009) , although they are expressed in different numbers of isoforms, ranging from only one FMO in yeast to five isoforms in vertebrates and to a large gene family in plants. FMOs directly recruit reducing equivalents from NAD(P)H without requiring any accessory proteins for enzyme activity (Phillips & Shephard, 2008) .
FMOs, at least in vertebrates, mainly contribute to an efficient biotransformation and detoxification system for xenobiotics, converting nucleophilic heteroatom-containing ISSN 2059-7983 # 2018 International Union of Crystallography compounds (such as amines, amides, thiols and sulfides) into polar, readily excretable metabolites (Cashman, 2001; Ziegler, 2002) .
During evolution, different insect lineages have developed specialized FMOs, pyrrolizidine alkaloid N-oxygenases (PNOs), as a counterstrategy to cope with pyrrolizidine alkaloids (PAs), which are toxic compounds that are produced by certain angiosperm species as part of their chemical defence against herbivores (Hartmann & Ober, 2008) . PAs are produced by plants in their nontoxic polar N-oxide form. After ingestion by a vertebrate or insect herbivore, PAs are converted into the protoxic free base in the reducing gut milieu (Fig. 1 ). Owing to their lipophilic properties, free bases easily permeate membranes and are bioactivated to reactive pyrrolic compounds by cytochrome P450 monooxygenases that are part of the xenobiotic metabolism of the herbivore (Fu et al., 2004) .
PA N-oxygenases are the only functionally characterized FMOs found to date in insects. They are one of various strategies of adapted insects to avoid high concentrations of toxic PAs in their haemolymph by enzymatically stabilizing the nontoxic N-oxide (Fig. 1 ). This mechanism is realized in the larvae of arctiid moths (Hartmann et al., 1990; Sehlmeyer et al., 2010; Naumann et al., 2002) , Longitarsus flea beetle species (Narberhaus et al., 2003) and the grasshopper genus Zonocerus (Bernays et al., 1977; Wang et al., 2012) . Identical selection pressure upon different insect lineages has led to the independent yet convergent evolution of FMOs with almost identical substrate specificity in these organisms (Wang et al., 2012) .
Three isoforms of flavin-dependent monooxygenase from the locust Z. variegatus (ZvFMOs) have been identified, named ZvFMOa, ZvFMOc and ZvPNO. They all share a similar substrate spectrum and are able to oxygenate a variety of different PAs. However, they exhibit quite different enzyme activities. While ZvPNO is the most potent isoform, ZvFMOa and ZvFMOc show a specific activity that is eightfold to 300-fold lower, depending on the PA substrate. The high degree of amino-acid sequence identity (77-77.8%) between the various ZvFMOs combined with their similar substrate spectra indicates a duplication event of a common ancestor FMO-coding gene that already possessed PA N-oxygenating capabilities and was subsequently recruited and optimized for plantderived PAs (Wang et al., 2012) .
The FMO reaction cycle had been investigated before the first structures became available, and is widely distributed in the literature. Class B FMOs such as those from Z. variegatus consist of two domains, each of which contains a dinucleotidebinding domain in the form of a Rossmann fold, which is responsible for cofactor binding. In its native state, oxidized FAD is tightly bound to the enzyme as a prosthetic group. NADPH is recruited as a co-substrate and transfers reducing equivalents to FAD. Upon the reaction of reduced FAD by molecular oxygen, a C4a-hydroperoxy-FAD intermediate is formed. This intermediate is capable of inserting one O atom into a substrate compound and ends up as C4a-hydroxy-FAD, which may then release the second O atom as part of a water molecule, restoring the oxidized FAD cofactor (Ziegler, 2002; Robinson et al., 2013) . A cocked-gun mechanism has been proposed for the reaction cycle of FMOs, meaning that the activated C4a-hydroperoxy-FAD intermediate can be stabilized within the enzyme until a substrate accesses the active site and is then immediately oxygenated (Cashman, 1995; Ziegler, 1993) . The presence of NADP + seems to be crucial for the stabilization of this intermediate and therefore it has to remain bound to the enzyme throughout the whole catalytic cycle, making it the last compound to be released from the enzyme (Beaty & Ballou, 1981) .
Here, we present two crystal structures: (i) the pyrrolizidine alkaloid N-oxygenase (ZvPNO) from Z. variegatus with bound FAD and (ii) ZvPNO in complex with FAD and NADP + . In addition, we present data on ZvFMOa variants, which are discussed in terms of a better understanding of substrate conversion as well as the evolutionary background and specialization of FMOs in insects. The crystal structures presented in this study are the first available FMO structures to originate from more highly developed eukaryotes. Our data show a flexible helix close to the active site which is likely to be involved in substrate binding and/or product release and has not been described before in other FMO structures. Although ZvFMO isoforms are dimeric in solution, as is frequently observed for other members of the FMO family, their specific arrangement of the two subunits is unique. Of note, the contact area is rather small; nevertheless, the dimer is very stable in solution. N-Oxygenation of pyrrolizidine alkaloids by ZvFMOs. Upon ingestion, plant-derived PAs are reduced to their protoxic tertiary amine form within the gut of the herbivore (Langel & Ober, 2011) . (a) In adapted insects such as Zonocerus, protoxic PAs are efficiently converted to the respective PA N-oxides by ZvFMOs. PAs are esters of the bicyclic necine base moiety with one or more necic acids that are represented by R 1 and R 2 (Hartmann & Witte, 1995) . (b) During this study, the PA monocrotaline was used as a substrate to characterize the different FMOs from Zonocerus.
Experimental procedures

Generation of expression plasmids for ZvFMO isoforms and variants
The identification of three different ZvFMO isoforms (ZvFMOa, ZvFMOc and ZvPNO) and the generation of individual expression plasmids have been described previously (Wang et al., 2012) . Expression vectors for the ZvFMOa variants were generated according to the QuikChange sitedirected mutagenesis protocol (Stratagene, La Jolla, California, USA) using Phusion high-fidelity DNA polymerase (Fermentas) with the pET-22b-ZvFMOa plasmid as a template and the following primers: ZvFMOa variant F307Y, forward, 
Expression and purification of ZvFMOs
ZvFMO isoforms as well as their variants were heterologously expressed in E. coli BL21(DE3) cells harbouring the respective recombinant plasmids. Cells were grown at 210 K in LB medium containing 100 mg ml À1 ampicillin (for pET-22b-derived vectors) or 30 mg ml À1 kanamycin (for pET-28a-derived vectors). Protein expression was induced by adding 0.1 mM isopropyl -d-1-thiogalactopyranoside (IPTG) to the bacterial cultures at an OD 600 of 0.6 followed by incubation at 297 K for 16 h. The cells were lysed using an EmulsiFlex-C3 (Avestin, Mannheim, Germany) and subsequently centrifuged at 75 600g for 1 h. His 6 -tagged recombinant proteins were purified from the resulting crude extract via immobilized metal ion-affinity chromatography (IMAC) using a HisTrap HP 5 ml column and an Ä KTApurifier FPLC system (both from GE Healthcare, Freiburg, Germany). The lysis and equilibration buffer was composed of 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 20 mM imidazole, 10 mM -mercaptoethanol, 200 mM phenylmethanesulfonyl fluoride (PMSF). Proteins were eluted via a linear gradient over five column volumes to a final concentration of 500 mM imidazole. Eluted target protein fractions were pooled and subsequently subjected to size-exclusion chromatography (HiLoad 16/60 Superdex 200 pg, GE Healthcare) with a running buffer composed of 20 mM glycine pH 9.0, 200 mM NaCl, 5 mM DTT. Purified protein was concentrated to approximately 6 mg ml À1 and stored in 20 mM glycine pH 9.0, 1 mM DTT at 193 K.
SEC-MALS analysis
In order to determine the oligomeric states of the purified ZvFMO proteins, HPLC-based size-exclusion chromatography (SEC) with refractive-index (RI) and multi-angle laser light-scattering (MALS) detectors was performed. Protein solutions were diluted to 4 mg ml À1 in phosphate-buffered saline (PBS) buffer pH 7.0 prior to SEC-MALS analysis. The HPLC-SEC system consisted of an online vacuum degasser (S 8515; SRI Instruments Europe), a high-pressure quaternary pump (G1311A; Agilent Technologies), a manual injector (7725i; Rheodyne), a pre-column (WTC-030N5G, 4.6 Â 50 mm; Wyatt Technology), a SEC column (WTC-030N5, 4.6 Â 300 mm; Wyatt Technology), a MALS detector (mini-DAWN TREOS, = 658 nm; Wyatt Technology) and a RI detector (G1362; Agilent Technologies). Data acquisition and processing were carried out using the ASTRA software (Wyatt Technology). The mobile phase for the SEC-MALS analysis was PBS (adjusted to pH 7.0 with phosphoric acid) and the flow rate was 0.4 ml min
À1
. Additionally, the SEC column was calibrated with a protein-standard mixture containing bovine thyroglobulin, bovine gamma globulin, chicken ovalbumin and bovine ribonuclease A. Retention times were correlated with molecular weight and used to determine the oligomeric states of the ZvFMOs.
Crystallization
Initial crystallization hits were identified by highthroughput screening performed at the SPC Facility at EMBL Hamburg. Crystallization experiments for the refinement of the initial conditions were carried out using the hanging-drop vapour-diffusion method at 291 K. ZvPNO crystals were obtained by mixing protein solution (5.6 mg ml À1 in 20 mM glycine-NaOH pH 9.0, 1 mM DTT) with an equal amount of precipitant solution [20 mM Tris-HCl pH 7.0, 200 mM MgCl 2 , 15%(w/v) PEG 3350]. In order to generate crystals of ZvPNO in complex with the oxidized NADP cofactor, 1 mM NADP + was added to the precipitant solution for co-crystallization. Crystals of wild-type ZvFMOa were obtained by mixing the protein solution (6.5 mg ml À1 in 20 mM glycine-NaOH pH 9.0, 1 mM DTT) with an equal amount of precipitant solution [20 mM bis-tris propane-NaOH pH 7.5, 200 mM NaNO 3 , 22%(w/v) PEG 3000, 1 mM TMA-HCl, 1 mM NADP + ]. Drops were equilibrated against reservoir solution. Crystals appeared after 2-4 d in the form of mostly rod-shaped clusters or displaying multiple lattices. A few single crystals could be isolated and were briefly equilibrated in cryoprotectant solution prior to flash-cooling in liquid nitrogen. ZvPNO-FAD crystals were equilibrated in 3.2 M trimethylamine N-oxide (TMAO) for cryoprotection. Crystals of ZvPNO in complex with oxidized NADP cofactor as well as ZvFMOa crystals research papers were equilibrated in 67%(v/v) reservoir solution in deionized water supplemented with a final concentration of 27.4%(w/v) PEG 3000.
Co-crystallization and soaking experiments
Co-crystallization experiments were carried out using the abovementioned crystallization conditions additionally supplied with 0.5-1 mM senecionine, 0.5-7.6 mM atropine, 3-33 mM homatropine hydrobromide or 14-154 mM atropine sulfate. The same PA substrate solutions and concentrations were used for soaking experiments. Soaking was performed by transferring crystals into the respective cryoprotectant solution (supplied with different amounts of substrates) for 5 min at 291 K before flash-cooling in liquid nitrogen.
ZvFMO activity assay
The activity of ZvFMO was determined photometrically using an Ultrospec 2100 pro (GE Healthcare, Freiburg, Germany). All substances were dissolved or diluted in glycine buffer (100 mM glycine-NaOH, pH 9.0). 340 ml of diluted enzyme (0.2 mg ml
À1
) was incubated in a UV cuvette for 1 min at 303 K. 40 ml of 2 mM NADPH solution was added and incubated at 30 C for another minute. The enzymatic reaction was started by adding 20 ml of monocrotaline solution (2 mg ml À1 ). NADPH turnover was monitored at 340 nm and directly correlated to N-oxygenation of monocrotaline.
2.7. Data collection, structure determination and representation X-ray diffraction data were collected at 100 K on MX beamline P14, EMBL/DESY PETRA III (Hamburg, Germany) equipped with a PILATUS 6M detector. Diffraction data were indexed and integrated using the XDS software (Kabsch, 2010) . Space-group determination, data scaling and merging were performed by the AIMLESS software as part of the CCP4 program suite , while applying the free-R flag to 5% of reflections. The structure of ZvPNO without cofactors was solved by molecular replacement (MR) using the MOLREP software as implemented in the CCP4 program suite. The starting model for MR was built based on the bacterial FMO from Methylophaga aminisulfidivorans (PDB entry 2xve, subunit A, 3. Results
Expression, purification, crystallization and data collection
All ZvFMO isoforms were overproduced in E. coli and purified via FPLC. The enzymes eluted as stable, dimeric, 421-425-residue proteins (depending on the isoform) with a characteristic flavoprotein absorption maximum at 450 nm. The oligomeric state was separately confirmed by SEC-MALS analysis. All isoforms were subjected to crystallization trials, yet only ZvPNO yielded high-quality crystals that were suitable for X-ray diffraction experiments and subsequent structure determination. Crystal structures of the ZvPNO-FAD and ZvPNO-FAD-NADP + complexes were determined to resolutions of 1.9 and 1.6 Å , respectively. 12 C-terminal residues (including the hexahistidine affinity tag) as well as residues 216-223 could not be modelled owing to the absence of appropriate electron density. The electron-density maps for the rest of the model were of high quality. Co-crystallization and soaking experiments with low substrate concentrations yielded crystals that were suitable for structure determination. However, no additional electron density could be observed within the active site which could be interpreted as substrate. Using higher amounts of different substrates for co-crystallization resulted in the formation of amorphous precipitate rather than protein crystals. Crystals which were soaked with higher substrate concentrations immediately showed cracks when transferred to the soaking solution and began to dissolve after a few seconds. Protein crystals as well as data sets were also obtained for the isoform ZvFMOa, but owing to poor crystal quality and the resulting poor data statistics no reliable model could be determined for this isoform with regard to specific side-chain arrangements. However, the obtained diffraction data were sufficient for MR phasing, C tracing and analysis of the crystal packing as well as the dimeric arrangement. No crystallization condition was identified for the ZvFMOc isoform, even after screening using ZvPNO crystals for cross-seeding.
Overall structure of ZvPNO
ZvPNO is composed of two structural domains, each of which exhibits a dinucleotide-binding Rossmann fold crucial for binding either the FAD or the NADP cofactor. While FAD is tightly bound to the large structural domain composed of amino-acid residues 1-155 and 260-425, NADP + is more loosely bound to the small domain (residues 156-259), where it can easily be exchanged for its reduced equivalent. The substrate-binding site is located within the cleft formed by the two domains, in direct proximity to the flavin moiety of the FAD, the ribose of NADP + and the highly conserved aminoacid residue Asn66 (Fig. 2) .
FAD binding
The FAD cofactor is deeply anchored within the large structural domain via the formation of hydrogen bonds to polar or charged amino-acid side chains (residues Ser12, Glu31 and Thr39) as well as N and O atoms of the protein backbone (residues Ser12, Thr39, Asn66 and Val115). It is further held in position by numerous coordinated water molecules and hydrophobic residues, which define a major part of the binding site for this cofactor (Fig. 3) . The typical dinucleotidebinding motif GXGXXG is represented by residues 8-13. Only the reactive flavin moiety extends towards the solventexposed cleft encircled by the two structural domains and is accessible to NADPH, molecular oxygen and substrates.
NADP + binding
The NADP + cofactor is bound to the GXGXXG motif (residues 191-196) of the smaller structural domain in an extended conformation via hydrogen bonds to its diphosphate moiety. The 2 0 phosphate of NADP + is coordinated by Lys223 and His351. Interactions between the nicotinamide moiety and Phe64 and Arg398 as well as between the ribose moiety and Asn66 further support the binding and positioning of the cofactor (Fig. 3) . In comparison to the ZvPNO-FAD complex, the presence of NADP + leads to a small conformational change of helix 4 such that it provides additional cofactor stabilization by interactions between a positive partial charge of the helix dipole and the diphosphate of NADP + (Fig. 4) . The conformational change in the preceding loop region is caused by a flipping alanine, which reduces steric hindrance when binding the NADP + cofactor.
Active site and substratebinding cleft
The active site of ZvPNO is located in direct proximity to the functional moieties of both dinucleotide cofactors in combination with Asn66, which is highly conserved among FMOs. The ribose moiety of NADP + and Asn66 are supposed to coordinate molecular oxygen and stabilize the C4a-hydroperoxy-FAD intermediate (Eswaramoorthy et al., 2006; Olucha et al., 2011; Hille et al., 2013) . This is supported by an elongated electron-density feature found in this position in at least one chain of the ZvPNO-FAD-NADP + crystal structure, which was interpreted as two neighbouring water molecules but could also account for molecular oxygen. The rest of the substrate-binding pocket is formed by Asn66, Leu67, Pro194, Phe383, Val386, Tyr307 and Tyr303-Ala305, while the entrance is further restricted by a loop composed of Val354, Met356, Asn357 and Gln359 (Fig. 5) .
As in most enzymes, the binding pocket of ZvPNO is not static but exhibits some flexibility. Small conformational changes were observable on comparing different protein subunits within the unit cell, accounting for some degree of structural plasticity. The most prominent among them is helix 8 composed of Pro377-Lys392, which can be kinked to a certain degree. Thereby, the space available for substrate binding is partly occupied (Fig. 6) . The flexibility of this part of helix 8 is further indicated by higher B factors. In addition, the electron density for the side-chain atoms of Leu67 reveals different rotamer conformations when comparing the four protein molecules comprising the asymmetric unit. Depending on the conformation of Leu67, the volume of the binding pocket at the reaction centre is slightly reduced or enhanced, respectively.
Dimer formation
Despite the differences in sequence, the overall structures of the flavin-dependent monooxygenases are very similar. This indicates the need for high conservation of the threedimensional structure for this type of reaction. For the biological assembly, a broader variation can be observed. Many functional assemblies of FMOs are known to be homo-oligomers (dimers, tetramers or hexamers), but the interfaces that contribute to oligomer formation seem to be unpredictable. The published crystal structures of dimeric FMOs reveal quite different dimeric arrangements (Malito et al., 2004; Leisch et al., 2012; Eswaramoorthy et al., 2006; Cho et al., 2011) , none of which are shared by the structures presented in this study. For all ZvFMO isoforms the major fraction was identified as a dimer by SEC-MALS analysis and calibrated SEC ( Fig. 7 ; results are only shown for ZvPNO). Symmetrical homodimers with twofold symmetry can be observed within the ZvPNO crystal structure, however, with a new type of orientation (Fig. 8) . Contacts are provided by hydrogen bonds and salt bridges between the large domain of one subunit (residues Trp47, Val55, Glu116, Trp153 and Arg264) and the small domain of the symmetry mate (residues Arg167, Glu239 and Trp240). With the exception of Val55, which is only involved via its backbone atoms, these residues are shared by all three ZvFMO isoforms. Of note, Arg167 is also part of the signature sequence (residues 166-176), which is highly conserved among FMOs (Fraaije et al., 2002) . Despite the few contact sites and the rather small interface area of approximately 900 Å 2 (calculated by PDBePISA; Krissinel & Henrick, 2007) a crystallographic artefact can be ruled out by the nonrefined crystal structure of ZvFMOa. It exhibits the same dimeric arrangement of subunits, but a different crystal packing of these dimers. The substrate-binding sites of the two enzyme molecules forming the biologically active ZvFMO dimer are not occupied by the interface area and are fully solvent-accessible. The two active sites point in opposite directions, which enhances the possibility of cofactor and substrate recruitment in a rather orientation-independent manner. Based on this new dimeric arrangement, it seems that the relative orientation of the protein subunits is not crucial for the enzymatic reaction.
Sequence alignment of ZvFMO isoforms
All ZvFMO isoforms share high sequence identity (77.7% between ZvPNO and ZvFMOa; 77.1% between ZvPNO and ZvFMOc; 82.8% between ZvFMOa and ZvFMOc). Still, their specific enzyme activities significantly diverge from each other, probably owing to differences in the substrate-binding pocket or substrate-entry path (Fig. 9) . In contrast, the sequence identities of ZvPNO compared with its modelling templates from M. aminisulfidivorans (34% sequence identity; r.m.s.d. of 2.5 Å ) and Schizosaccharomyces pombe (27% sequence identity; r.m.s.d. of 2.3 Å ) are rather low.
ZvFMOa variants
Variants of the less active isoform ZvFMOa were generated to identify amino-acid residues which have an impact on the specific activity of this enzyme and are likely to be involved in substrate binding or turnover. We investigated residues which are part of the substrate-binding pocket and differed between the ZvPNO and ZvFMOa isoforms. Based on initial docking experiments with the crystal structure of ZvPNO and different PA substrates, Tyr307 was identified as the most promising part of the binding pocket, potentially forming hydrogen bonds to a variety of PA substrates. Additionally, when comparing the crystal structures of ZvPNO with a homology model of ZvFMOa, a tyrosine residue (Tyr356) blocking the substrate entrance in the latter model was observed. Thus, the Dimeric arrangement of ZvPNO. Cartoon representation of two ZvPNO subunits (blue and yellow). Interface residues are depicted as stick models. The view is along the noncrystallographic twofold dyad. The surface-complementarity score was calculated to be 0.8 (Lawrence & Colman, 1993) .
were investigated. In contrast to preliminary substratedocking predictions, the ZvFMOa F307Y variant resulted in a decline in specific activity by a factor of 0.81 in comparison with wild-type ZvFMOa (Fig. 10) , while the double variant exhibited a slight increase by a factor of 1.51. Consequently, a variant containing a single Y356A exchange was generated and analysed. The specific activity of this variant was increased by a factor of 2.45 compared with the wild-type enzyme. Therefore, another variant (F354V) was created which likewise contained an amino-acid exchange within the loop limiting the entrance to the binding site. This exchange also resulted in an increased specific activity (by a factor of 2.75).
However, combining both favourable amino-acid exchanges does not result in a higher level of specific activity, but rather diminishes their individual effects. Still, the observed specific activity for this double variant is increased by a factor of 1.5 compared with the control experiment. The beneficial effect of a more accessible substrateentry path might possibly be partly antagonized by a loss of substrate affinity when both bulky aromatic amino acids are exchanged for smaller substituents. Based on our identification of the flexible helix 8, which might have an influence on substrate binding and turnover, we also generated a P388S variant. However, the specific activity of this variant did not differ significantly from that of wild-type ZvFMOa, indicating that the presence of proline within the ZvFMOa helix does not interfere with its potential role in substrate turnover.
Discussion
The structure of ZvPNO represents that of an FMO from the highest eukaryotic organism currently available. FMOs oxidize a large number of structurally very diverse substrates. The determinants for the selectivity or even specificity for the individual substrates are defined by residues surrounding the substratebinding path. The specific activity of ZvFMO seems to depend on the accessibility of the active site, rather than on specific interactions between the binding pocket and different PA substrates. In order to be able to accommodate a rather diverse set of substrates, a need for rather large structural Structure-based sequence alignment of ZvFMO isoforms. Red background, identical amino acids; bold letters, similar amino acids; blue boxes, residues forming the predicted substrate-binding pocket. The multiple sequence alignment was performed with Clustal Omega (Sievers et al., 2011) ; the final figure was prepared using ESPript (Robert & Gouet, 2014) . The secondary structure was derived by DSSP (Kabsch & Sander, 1983 ) and is depicted above the sequences. Residues which were exchanged by site-directed mutagenesis are highlighted by a triangle below the sequence. plasticity within this pocket can be envisaged. Substrates are presumably not firmly bound to the enzyme but are instantly oxygenated upon reaching the active site. These findings coincide with the broad PA substrate spectrum of ZvFMOs as well as the proposed cocked-gun mechanism for these enzymes. It might also be possible that an active C4a-hydroperoxy-FAD intermediate structure may preferably bind the PA ligand compared with the oxidized FAD structure as presented. These circumstances might be the reason for our unsuccessful co-crystallization and soaking experiments and the lack of structural evidence for an enzyme-substrate complex.
Still, the active site and substrate-binding cleft of ZvPNO show some flexibility, especially in helix 8, which either reduces or enhances the volume of the binding pocket depending on its bending angle. This flexibility might account for either one of two features: (i) it might contribute to an induced fit to best adapt to different PA substrates or (ii) it might serve as some kind of product-removal mechanism by mechanically pushing the oxygenated PA out of the active site.
Of note, only the space in direct proximity to the reactive flavin moiety is quite limited, while the rest of the substratebinding pocket is largely solvent-exposed and exhibits few steric boundaries. Therefore, the small active site only accepts small compounds such as molecular oxygen, which is needed for the oxygenation reaction, and is probably selective for structural features that resemble a necine base, which is shared by all PA substrates. Otherwise, there seems to be very limited selectivity regarding accepted substrates apart from the steric hindrance present in the entrance site of the binding cleft. This is backed up by our findings that single amino-acid exchanges within the ZvFMOa sequence could significantly increase its specific activity towards one of the sterically most demanding PA substrates, monocrotaline.
Therefore, ZvFMOs are not specialists with high efficiency towards a single substrate, but rather generalists which accept a variety of compounds with similar features. This harbours a great advantage for the host organism Zonocerus, which can easily adapt to a variety of PAs produced by food plants and thereby circumvent their chemical defence against herbivory as part of the so-called arms race between plants and their attackers (Pieterse & Dicke, 2007) . Evolutionary pressure caused by ever-developing PAs in the host plants might be a reason for this organism to retain three isoforms of ZvFMOs with differences in their substrate-binding cleft in its genome, although two of them are far less active towards currently known PAs. A few mutations during the course of evolution might turn them into highly active enzymes capable of oxygenating PAs, as our studies of ZvFMOa variants have already indicated. However, it cannot be ruled out that the real substrates for isoform A and isoform C have not yet been identified.
Owing to their structural and catalytical properties, the ZvFMO isoforms belong to the class B flavoprotein monooxygenases (van Berkel et al., 2006) . To date, our structural knowledge about this specific FMO subclass is solely based on FMO crystal structures from bacteria, yeast and fungi (Malito et al., 2004; Eswaramoorthy et al., 2006; Cho et al., 2011; Mirza et al., 2009; Olucha et al., 2011; Yachnin et al., 2012; Leisch et al., 2012; Jensen et al., 2012 Jensen et al., , 2014 Franceschini, Fedkenheuer et al., 2012; Franceschini, van Beek et al., 2012; Binda et al., 2015; Setser et al., 2014; Ferroni et al., 2016; Romero et al., 2016; Fü rst et al., 2017) . Therefore, the structures presented here are the first to derive from a more highly developed organism and give insight into the evolutionary conservation of FMOs. Although displaying a unique dimer interface, the overall structure of the FMO subunits has remained largely unchanged throughout evolution. However, the detailed mechanisms of cofactor and substrate binding as well as product release from the active site, which are conducted by minor and major conformational changes within the active site, are still not fully understood. The identification of a kink within the flexible helix 8 presented in this work might contribute to a better future understanding of the complete machinery.
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